|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2004-7-8
|
|
pubmed:abstractText |
Hepatocellular carcinoma (HCC) is the fifth most common cancer around the world. Although several therapeutic approaches for treatment of HCC are available, survival rates for HCC patients are still very poor because of inefficient treatment options. For HCC, as well as other tumors, antigen-specific immunotherapy remains a viable approach that is dependent on the definition of tumor-associated antigens. NY-ESO-1, a member of the cancer testis antigen family, is one possible candidate for a tumor-specific antigen in HCC. The aim of this study was to show the relevance of NY-ESO-1 in hepatocellular carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD14,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/CTAG1B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chromium Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4332-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15240519-Adult,
pubmed-meshheading:15240519-Aged,
pubmed-meshheading:15240519-Aged, 80 and over,
pubmed-meshheading:15240519-Antibodies,
pubmed-meshheading:15240519-Antigens, CD14,
pubmed-meshheading:15240519-Antigens, Neoplasm,
pubmed-meshheading:15240519-Blotting, Western,
pubmed-meshheading:15240519-CD4-Positive T-Lymphocytes,
pubmed-meshheading:15240519-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15240519-Carcinoma, Hepatocellular,
pubmed-meshheading:15240519-Cell Line, Tumor,
pubmed-meshheading:15240519-Chromium Radioisotopes,
pubmed-meshheading:15240519-Dendritic Cells,
pubmed-meshheading:15240519-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15240519-Epitopes, T-Lymphocyte,
pubmed-meshheading:15240519-Female,
pubmed-meshheading:15240519-Flow Cytometry,
pubmed-meshheading:15240519-Humans,
pubmed-meshheading:15240519-Immunoblotting,
pubmed-meshheading:15240519-Immunotherapy,
pubmed-meshheading:15240519-Male,
pubmed-meshheading:15240519-Membrane Proteins,
pubmed-meshheading:15240519-Middle Aged,
pubmed-meshheading:15240519-Peptides,
pubmed-meshheading:15240519-RNA, Messenger,
pubmed-meshheading:15240519-Recombinant Proteins,
pubmed-meshheading:15240519-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:15240519-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
|
|
pubmed:affiliation |
Department of Gastroenterology, Hepatology and Endocrinology, Clinic of Visceral and Transplantation Surgery, Medizinische Hochschule Hannover, Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
